Carlos M. DeCastro

3.9k citations

56 papers · 2.9k indexed · 1 hit paper · h-index 21

Hematology top 0.5%
Molecular Biology top 10%
Genetics top 1%
Immunology top 5%
Epidemiology top 10%

Co-authors: James F. Holland Jimmie C. Holland Richard A. Larson John Ellerton Rosalie Odchimar-Reissig Bayard L. Powell Erin P. Demakos Charles A. Schiffer
Topics: Acute Myeloid Leukemia Research (12 papers)Cardiac Valve Diseases and Treatments (10 papers)Lymphoma Diagnosis and Treatment (10 papers)
Cited by: Hematology Genetics Immunology
Journals: Proceedings of the National Academy of Sciences Journal of Clinical Oncology Blood
Partner nations: United States United Kingdom Japan

In The Last Decade

Carlos M. DeCastro

53 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B

2002 1.3k citations Carlos M. DeCastro et al. profile →

Peers

Countries citing papers authored by Carlos M. DeCastro

Since Specialization

Citations

This map shows the geographic impact of Carlos M. DeCastro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos M. DeCastro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos M. DeCastro more than expected).

Fields of papers citing papers by Carlos M. DeCastro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos M. DeCastro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos M. DeCastro. The network helps show where Carlos M. DeCastro may publish in the future.

Co-authorship network of co-authors of Carlos M. DeCastro

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos M. DeCastro. A scholar is included among the top collaborators of Carlos M. DeCastro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos M. DeCastro. Carlos M. DeCastro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	RESULTS OF THE PEGASUS PHASE 3 RANDOMIZED TRIAL DEMONSTRATING SUPERIORITY OF THE C3 INHIBITOR PEGCETACOPLAN COMPARED TO ECULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 2020 ·Hematology Transfusion and Cell Therapy ·Howard H. Weitz,Peter Hillmen,Jeff Szer,A Roth,Britta Höchsmann,Jens Panse,Kenneth Y. Usuki,Maura Griffin,Jean‐Jacques Kiladjian,Carlos M. DeCastro,Hiroyuki Nishimori,Lisa Tan,(unknown),Pascal Deschatelets,Cedric Francois,F Grossi,(unknown),Régis Peffault de Latour	2
2	Phase II open label study of the oral vascular endothelial growth factor-receptor inhibitor PTK787/ZK222584 (vatalanib) in adult patients with refractory or relapsed diffuse large B-cell lymphoma 2013 ·Leukemia & lymphoma ·Danielle M. Brander,David A. Rizzieri,Jon P. Gockerman,Louis F. Diehl,Thomas C. Shea,Carlos M. DeCastro,Joseph O. Moore,Anne Beaven	5
3	Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemia 2012 ·Leukemia Research ·(unknown),Carlos M. DeCastro,Louis F. Diehl,Jon P. Gockerman,Anand S. Lagoo,Zhiguo Li,Joseph O. Moore,David A. Rizzieri,Arati V. Rao	31
4	Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia 2011 ·Leukemia & lymphoma ·Mark C. Lanasa,Patricia H. Davis,Michael Datto,Zhiguo Li,Jon P. Gockerman,Joseph O. Moore,Carlos M. DeCastro,Daphne R. Friedman,Louis F. Diehl,Catherine Rehder,Harry Cook,(unknown),Karen Matta,J. Brice Weinberg,David A. Rizzieri	11
5	Overcoming Drug Resistance in Mantle Cell Lymphoma Using a Combination of Dose-Dense and Intense Therapy 2010 ·Cancer Investigation ·(unknown),Liang‐Piu Koh,Jon P. Gockerman,Joseph O. Moore,Carlos M. DeCastro,Gwynn D. Long,Louis F. Diehl,Christina Gasparetto,Donna Niedzwiecki,(unknown),Leonard R. Prosnitz,Mitchell E. Horwitz,(unknown),Ashley Morris,Patricia H. Davis,Anne Beaven,Nelson J. Chao,Francis Ali‐Osman,David A. Rizzieri	1
6	A Genomic Approach to Improve Prognosis and Predict Therapeutic Response in Chronic Lymphocytic Leukemia 2009 ·Clinical Cancer Research ·Daphne R. Friedman,J. Brice Weinberg,William T. Barry,Barbara K. Goodman,Alicia D. Volkheimer,(unknown),Youwei Chen,Ning Jiang,Joseph O. Moore,Jon P. Gockerman,Louis F. Diehl,Carlos M. DeCastro,Anil Potti,Joseph R. Nevins	28
7	OP04 Safety and efficacy of the terminal complement inhibitor eculizumab in patients with paroxysmal nocturnal hemoglobinuria: Shepherd Phase III clinical study results 2007 ·Leukemia Research ·Petra Muus,Lucio Luzzatto,Bruno Rotoli,NS Young,J. Schubert,Álvaro Urbano-Ispizúa,(unknown),Carlos M. DeCastro,Chieh‐Lin Fu,J Maciejewski,(unknown),(unknown),Peter Hillmen,Hubert Schrezenmeier	4
8	Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia 2007 ·American Journal of Hematology ·J. Brice Weinberg,Alicia D. Volkheimer,Youwei Chen,(unknown),Ning Jiang,Mark C. Lanasa,Daphne R. Friedman,Gina M. Vaccaro,Catherine Rehder,Carlos M. DeCastro,David A. Rizzieri,Louis F. Diehl,Jon P. Gockerman,Joseph O. Moore,Barbara K. Goodman,Marc C. Levesque	36
9	Clinical Course and Flow Cytometric Analysis of Paroxysmal Nocturnal Hemoglobinuria in the United States and Japan 2004 ·Medicine ·Jun‐ichi Nishimura,Yuzuru Kanakura,Russell E. Ware,Tsutomu Shichishima,Hideki Nakakuma,Haruhiko Ninomiya,Carlos M. DeCastro,Sharon Hall,Akihisa Kanamaru,Keith M. Sullivan,Hideaki Mizoguchi,Mitsuhiro Omine,Taroh Kinoshita,Wendell F. Rosse	186
10	Low‐dose weekly paclitaxel for recurrent or refractory aggressive non‐Hodgkin lymphoma 2004 ·Cancer ·David A. Rizzieri,(unknown),Dean McGaughey,Joseph O. Moore,Carlos M. DeCastro,Nelson J. Chao,James J. Vredenburgh,Cristina Gasparetto,Gwynn D. Long,Elizabeth Anderson,Tracy Foster,(unknown),(unknown),Donna Niedzwiecki,Jon P. Gockerman	15
11	Rituximab in Lymphocyte Predominance Hodgkin's Disease: A Case Series 2003 ·Clinical Lymphoma ·(unknown),(unknown),Jerald Z. Gong,Joseph O. Moore,Carlos M. DeCastro,Leonard R. Prosnitz,David A. Rizzieri,Jon P. Gockerman	3
12	Increased expression of anti-apoptosis genes in peripheral blood cells from patients with paroxysmal nocturnal hemoglobinuria 2003 ·Molecular Genetics and Metabolism ·Matthew M. Heeney,(unknown),M. Anthony Moody,Thad A. Howard,Carlos M. DeCastro,Russell E. Ware	10
13	Circulating PIG-A mutant T lymphocytes in healthy adults and patients with bone marrow failure syndromes 2001 ·Experimental Hematology ·Russell E. Ware,(unknown),Carlos M. DeCastro,Thad A. Howard	38
14	Neural Cell Adhesion Molecule (CD56)–Positive Acute Myelogenous Leukemia and Myelodysplastic and Myeloproliferative Syndromes 1997 ·American Journal of Clinical Pathology ·Karen P. Mann,Carlos M. DeCastro,Jane Liu,Joseph O. Moore,Sandra H. Bigner,S. Thomas Traweek	36
15	Comparison of human and Xenopus GATA-2 promoters 1996 ·Gene ·Donald E. Fleenor,Scott Langdon,Carlos M. DeCastro,Russel E. Kaufman	17
16	Comparison of Dipyridamole-Echocardiography with Dipyridamole-Thallium Scintigraphy for the Diagnosis of Myocardial Ischemia 1991 ·Clinical Nuclear Medicine ·Emerson C. Perin,Warren H. Moore,(unknown),Guillermo Hernández,RAMESH D. DHEKNE,Carlos M. DeCastro	19
17	Doppler color-flow echocardiographic recognition of left ventricular pseudoanourysm 1988 ·American Heart Journal ·(unknown),(unknown),Guillermo Hernández,Carlos M. DeCastro,Earl F. Beard,Denton Cooley,Robert J. Hall	7
18	Two-dimensional echocardiographic assessment of complications involving the ionescu-shiley pericardial valve in the mitral position 1984 ·Journal of the American College of Cardiology ·Luis González Gutiérrez-Solana,(unknown),Carlos M. DeCastro,Tomas Klima,Denton A. Cooley	5
19	Initial diastolic indentation of the mitral valve in aortic insufficiency 1982 ·Journal of Clinical Ultrasound ·Dennis W. Rowe,(unknown),Carlos M. DeCastro,(unknown),Robert J. Hall	3
20	Isolated mitral valve replacement with the Kay-Shiley prosthesis 1980 ·Journal of Thoracic and Cardiovascular Surgery ·Thomas Bowen,Rostik Zajtchuk,(unknown),Carlos M. DeCastro	9

About Carlos M. DeCastro

Carlos M. DeCastro is a scholar working on Hematology, Genetics and Transplantation, having authored 56 papers that have together received 2.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (12 papers), Cardiac Valve Diseases and Treatments (10 papers) and Lymphoma Diagnosis and Treatment (10 papers). The work is most often cited by research in Hematology (1.6k citations), Genetics (644 citations) and Immunology (492 citations). Carlos M. DeCastro has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include James F. Holland, Jimmie C. Holland, Richard A. Larson, John Ellerton, Rosalie Odchimar-Reissig, Bayard L. Powell, Erin P. Demakos, Charles A. Schiffer, Alice B. Kornblith and Lewis R. Silverman. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact